Cite
HARVARD Citation
London, W. et al. (2017). Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials. Cancer. 123 (24), pp. 4914-4923. [Online].